🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 12-week, multicenter, randomized, double-blind, placebo-controlle...
Status
Completed
Location
Tuscaloosa VA Medical Center
Start Date
2014-10
Trial ID
NCT02277704
Treatments Being Tested
This is a Phase 3, randomized, parallel-group, double-blind, placebo-contro...
Status
Completed
Location
Tonix Clinical Site
Start Date
2019-12-09
Trial ID
NCT04172831
Treatments Being Tested
TNX-102 capsules \[formerly known as very low dose (VLD) cyclobenzaprine\] ...
Status
Completed
Location
107 Scripps Drive
Start Date
2013-09
Trial ID
NCT01903265
Treatments Being Tested
The goal of this clinical trial is to learn if a drug called TNX-102 SL wor...
Status
Recruiting
Location
IMA Clinical Research- Phoenix
Start Date
2026-06
Trial ID
NCT07621237
Treatments Being Tested
This is a Phase 3, randomized, parallel-group, double-blind, placebo-contro...
Status
Completed
Location
Tonix Clinical Site
Start Date
2022-04-06
Trial ID
NCT05273749
Treatments Being Tested
This is a 12-week, multicenter, randomized, double-blind, placebo-controlle...
Status
Withdrawn
Location
Aga Khan University Clinical Research Unit
Start Date
2022-10-14
Trial ID
NCT05372887
Treatments Being Tested
This is an open-label, extension trial designed to evaluate safety over 12 ...
Status
Terminated
Location
Phoenix
Start Date
2017-06-20
Trial ID
NCT03110575
Treatments Being Tested
This study will examine the safety and efficacy of TNX-102 SL to reduce ASR...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-03-25
Trial ID
NCT06636786
Treatments Being Tested